Fig. 2From: Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot studyFSS score is reduced in RRMS patients treated with A. paniculata compared to placebo during one year. Each point represents an individual score of patients measured at 0, 90, 180 and 360 days. A box-and-whisker plot with the minimum, 25th percentile, median, 75th percentile, and maximum values are depictedBack to article page